Biotech

All Articles

8 months after a $213M fundraise, gene publisher Tome helps make cuts

.After raising $213 million in 2023-- some of the year's largest personal biotech rounds-- Volume Bi...

BioMarin creates officer crew along with biotech vets-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our summary of notable management hirings, shootings and al...

Biopharma Q2 VC hit highest degree due to the fact that '22, while M&ampA slowed down

.Venture capital backing into biopharma cheered $9.2 billion across 215 deals in the second quarter ...

Bicara, Zenas seek IPOs to press late-phase possessions toward market

.Bicara Therapies and Zenas Biopharma have actually provided new incentive to the IPO market with fi...

Genentech to shut cancer immunology study division

.Genentech will certainly shut its cancer immunology research team, and device head and renowned cel...

Kezar drops solid lump but to verify its truly worth in phase 1 trial

.Kezar Lifestyle Sciences is actually losing its unpromising period 1 solid growth medicine as the b...

Acelyrin drops izokibep, lets go 3rd of workers

.Despite izokibep preserving its newfound winning streak in the clinic, Acelyrin is actually no long...

Rivus' phase 2 obesity-related cardiac arrest trial strikes endpoint

.Rivus Pharmaceuticals has plumped up the potential customers of its fat-busting, muscle-sparing med...

Ovid halts preclinical work, IV plan after soticlestat fail

.Ovid Therapeutics already uncovered final month that it was actually trimming its own head count as...

Eli Lilly opens $700M nucleic acid R&ampD facility in Boston ma Seaport

.Eli Lilly has opened a $700 million R&ampD center in the Boston Port, boosting its RNA and also DNA...